🇺🇸 FDA
Patent

US 8119796

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P1/00A61P1/12

Quick answer

US patent 8119796 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/00, A61P1/12, A61P11/00, A61P11/02